Skip to main content

Table 4 Summary of the delayed post-procedural (day 28) angiography results

From: In vivo canine study of three different coatings applied to p64 flow-diverter stents: initial biocompatibility study

Animal number

Medication

Right CCA/ECA

Left CCA/ECA

Right SA

Left SA

1

None

p64 HPC-1, minimal stenosis

p64 uncoated, patent

p64 HPC-2, patent

p64 HPC-3, patent

2

ASA

p64 HPC-1, patent

p64 uncoated, patent

p64 HPC-2, severe stenosis

p64 HPC-3, complete stenosis

3

ASA

p64 HPC-2, patent

p64 HPC-1, patent

p64 HPC-3, patent

p64 uncoated, severe stenosis

4

ASA + clopidogrel

p64 HPC-2, patent

p64 HPC-1, patent

p64 HPC-3, patent

p64 uncoated, patent

  1. ASA acetylsalicylic acid, CCA common carotid artery, ECA external carotid artery, SA subclavian artery